| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SYRS | Syros Pharmaceuticals, Inc. | Roth David | Chief Medical Officer | Apr 03, 2024 | Sale | $4.95 | 10,451 | 51,732 | 0 | Apr 05, 2024, 04:30 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Stephens Kristin | Chief Development Officer | Apr 01, 2024 | Option Exercise | $5.12 | 4,218 | 21,596 | 25,237 | Apr 02, 2024, 05:01 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Simonian Nancy A | Director | Apr 01, 2024 | Option Exercise | $5.12 | 14,052 | 71,946 | 131,658 | Apr 02, 2024, 04:59 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Roth David | Chief Medical Officer | Apr 01, 2024 | Option Exercise | $5.12 | 4,732 | 24,228 | 10,601 | Apr 02, 2024, 04:58 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Roth David | Chief Medical Officer | Apr 02, 2024 | Sale | $4.98 | 150 | 747 | 10,451 | Apr 02, 2024, 04:58 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Quirk Gerald E | Chief Legal & Compliance Offic | Mar 28, 2024 | Option Exercise | $5.59 | 7,046 | 39,387 | 39,757 | Apr 02, 2024, 04:57 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Haas Jason | Chief Financial Officer | Apr 01, 2024 | Option Exercise | $5.12 | 4,732 | 24,228 | 24,552 | Apr 02, 2024, 04:54 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Chee Conley | President & CEO | Apr 01, 2024 | Option Exercise | $5.12 | 3,500 | 17,920 | 22,504 | Apr 02, 2024, 04:52 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | AKKARAJU SRINIVAS | Director | Dec 21, 2023 | Buy | $4.42 | 904,977 | 3,999,998 | 1,786,427 | Dec 26, 2023, 05:24 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Roth David | Chief Medical Officer | Dec 12, 2023 | Sale | $4.95 | 6,287 | 31,121 | 0 | Dec 14, 2023, 04:24 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Roth David | Chief Medical Officer | Dec 06, 2023 | Sale | $3.95 | 6,287 | 24,834 | 6,287 | Dec 08, 2023, 04:23 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Simonian Nancy A | President & CEO | Nov 01, 2023 | Option Exercise | $2.22 | 13,401 | 29,750 | 100,144 | Nov 02, 2023, 04:54 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Haas Jason | Chief Financial Officer | Nov 01, 2023 | Option Exercise | $2.22 | 6,301 | 13,988 | 13,951 | Nov 02, 2023, 04:53 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Roth David | Chief Medical Officer | Nov 01, 2023 | Option Exercise | $2.22 | 6,301 | 13,988 | 12,574 | Nov 02, 2023, 04:52 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Stephens Kristin | Chief Development Officer | Nov 01, 2023 | Option Exercise | $2.22 | 5,676 | 12,601 | 15,789 | Nov 02, 2023, 04:52 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Chee Conley | Chief Commercial Officer | Nov 01, 2023 | Option Exercise | $2.22 | 6,004 | 13,329 | 12,338 | Nov 02, 2023, 04:51 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Quirk Gerald E | Chief Legal & Compliance Offic | Oct 19, 2023 | Option Exercise | $2.10 | 6,897 | 14,484 | 24,303 | Oct 20, 2023, 04:23 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Roth David | Chief Medical Officer | Jul 31, 2023 | Sale | $3.95 | 7,348 | 29,025 | 0 | Aug 02, 2023, 04:21 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Olson Eric R | Chief Scientific Officer | Jul 17, 2023 | Sale | $3.50 | 689 | 2,412 | 6,661 | Jul 18, 2023, 08:27 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Haas Jason | Chief Financial Officer | Apr 03, 2023 | Option Exercise | $2.58 | 623 | 1,607 | 1,377 | Apr 04, 2023, 06:57 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Chee Conley | Chief Commercial Officer | Apr 03, 2023 | Option Exercise | $2.58 | 658 | 1,698 | 1,342 | Apr 04, 2023, 06:56 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Roth David | Chief Medical Officer | Apr 03, 2023 | Option Exercise | $2.58 | 623 | 1,607 | 7,348 | Apr 04, 2023, 06:56 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Stephens Kristin | Chief Development Officer | Apr 03, 2023 | Option Exercise | $2.58 | 623 | 1,607 | 4,465 | Apr 04, 2023, 06:55 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Olson Eric R | Chief Scientific Officer | Apr 03, 2023 | Option Exercise | $2.58 | 623 | 1,607 | 7,350 | Apr 04, 2023, 06:54 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Simonian Nancy A | President & CEO | Apr 03, 2023 | Option Exercise | $2.58 | 1,852 | 4,778 | 73,420 | Apr 04, 2023, 06:54 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | TYSON TIMOTHY | Director | Sep 29, 2022 | Buy | $5.72 | 2,932 | 16,770 | 10,932 | Oct 03, 2022, 04:42 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | TYSON TIMOTHY | Director | Sep 30, 2022 | Buy | $6.37 | 14,000 | 89,186 | 24,932 | Oct 03, 2022, 04:42 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Stephens Kristin | Chief Development Officer | Apr 01, 2022 | Option Exercise | $1.12 | 14,115 | 15,809 | 30,885 | Apr 04, 2022, 05:04 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Roth David | Chief Medical Officer | Apr 01, 2022 | Option Exercise | $1.12 | 27,281 | 30,555 | 59,719 | Apr 04, 2022, 05:03 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Olson Eric R | Chief Scientific Officer | Apr 01, 2022 | Option Exercise | $1.12 | 27,266 | 30,538 | 59,734 | Apr 04, 2022, 05:02 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Simonian Nancy A | President & CEO | Apr 01, 2022 | Option Exercise | $1.12 | 58,883 | 65,949 | 692,723 | Apr 04, 2022, 05:02 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Olson Eric R | Chief Scientific Officer | Jan 05, 2022 | Sale | $3.47 | 2,208 | 7,655 | 0 | Jan 06, 2022, 05:02 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Olson Eric R | Chief Scientific Officer | Jul 01, 2021 | Sale | $5.55 | 1,164 | 6,460 | 0 | Jul 01, 2021, 05:20 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Olson Eric R | Chief Scientific Officer | Mar 15, 2021 | Sale | $5.24 | 7,256 | 38,036 | 3,628 | Mar 17, 2021, 05:10 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Young Richard A | Director | Feb 16, 2021 | Sale | $12.05 | 3,750 | 45,188 | 321,711 | Feb 18, 2021, 05:34 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Young Richard A | Director | Feb 08, 2021 | Sale | $13.04 | 3,750 | 48,900 | 325,461 | Feb 10, 2021, 05:29 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Young Richard A | Director | Nov 16, 2020 | Sale | $8.98 | 633 | 5,684 | 334,568 | Feb 10, 2021, 05:28 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Young Richard A | Director | Nov 17, 2020 | Sale | $8.75 | 5,357 | 46,874 | 329,211 | Feb 10, 2021, 05:28 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Simonian Nancy A | President & CEO | Dec 18, 2020 | Option Exercise | $6.81 | 29,917 | 203,612 | 563,606 | Dec 21, 2020, 04:58 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Young Richard A | Director | Nov 16, 2020 | Sale | $8.98 | 633 | 5,684 | 344,568 | Nov 18, 2020, 04:33 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Young Richard A | Director | Nov 17, 2020 | Sale | $8.75 | 5,357 | 46,874 | 339,211 | Nov 18, 2020, 04:33 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Young Richard A | Director | Oct 19, 2020 | Sale | $8.75 | 5,673 | 49,639 | 335,201 | Oct 19, 2020, 06:36 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Young Richard A | Director | Oct 15, 2020 | Sale | $8.75 | 317 | 2,774 | 340,874 | Oct 16, 2020, 04:39 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Young Richard A | Director | Sep 15, 2020 | Sale | $10.39 | 5,990 | 62,236 | 341,191 | Sep 16, 2020, 08:32 AM | |
| SYRS | Syros Pharmaceuticals, Inc. | Olson Eric R | Chief Scientific Officer | Aug 17, 2020 | Option Exercise | $7.00 | 9,926 | 69,532 | 4,963 | Aug 19, 2020, 04:35 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Olson Eric R | Chief Scientific Officer | Aug 18, 2020 | Option Exercise | $7.00 | 21,574 | 151,126 | 10,787 | Aug 19, 2020, 04:35 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Young Richard A | Director | Aug 17, 2020 | Sale | $12.59 | 5,990 | 75,414 | 347,181 | Aug 19, 2020, 04:33 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | AKKARAJU SRINIVAS | Director | Aug 18, 2020 | Sale | $13.10 | 158,583 | 2,076,724 | 1,274,616 | Aug 19, 2020, 04:03 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | AKKARAJU SRINIVAS | Director | Aug 17, 2020 | Sale | $13.00 | 744 | 9,672 | 1,433,199 | Aug 19, 2020, 04:03 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Young Richard A | Director | Jul 15, 2020 | Sale | $11.85 | 5,990 | 70,982 | 353,171 | Jul 17, 2020, 04:11 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Olson Eric R | Chief Scientific Officer | Jul 07, 2020 | Sale | $11.72 | 1,753 | 20,538 | 0 | Jul 07, 2020, 07:33 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | AKKARAJU SRINIVAS | Director | Jul 01, 2020 | Sale | $11.01 | 4,627 | 50,966 | 1,433,943 | Jul 06, 2020, 04:00 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | AKKARAJU SRINIVAS | Director | Jun 25, 2020 | Sale | $11.15 | 54,972 | 612,850 | 1,438,570 | Jun 25, 2020, 08:38 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | AKKARAJU SRINIVAS | Director | Jun 23, 2020 | Sale | $11.11 | 50,953 | 565,930 | 1,542,317 | Jun 25, 2020, 08:38 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | AKKARAJU SRINIVAS | Director | Jun 24, 2020 | Sale | $11.07 | 48,775 | 539,788 | 1,493,542 | Jun 25, 2020, 08:38 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Young Richard A | Director | Jun 15, 2020 | Sale | $8.75 | 5,990 | 52,413 | 359,161 | Jun 16, 2020, 04:53 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Young Richard A | Director | May 15, 2020 | Sale | $9.22 | 5,990 | 55,242 | 365,151 | May 15, 2020, 05:13 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Alles Mark J | Director | May 13, 2020 | Buy | $8.86 | 10,000 | 88,590 | 10,000 | May 13, 2020, 05:05 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Young Richard A | Director | Apr 15, 2020 | Sale | $8.75 | 23,960 | 209,650 | 371,141 | Apr 17, 2020, 04:02 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Olson Eric R | Chief Scientific Officer | Feb 18, 2020 | Sale | $7.38 | 1,446 | 10,674 | 0 | Feb 20, 2020, 04:15 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Simonian Nancy A | President & CEO | Dec 23, 2019 | Option Exercise | $3.04 | 52,401 | 159,299 | 533,689 | Dec 23, 2019, 04:54 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Springhorn Jeremy P. | Chief Business Officer | Nov 11, 2019 | Buy | $4.99 | 9,879 | 49,328 | 24,879 | Nov 12, 2019, 04:34 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Springhorn Jeremy P. | Chief Business Officer | Nov 12, 2019 | Buy | $4.97 | 10,121 | 50,268 | 35,000 | Nov 12, 2019, 04:34 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Young Richard A | Director | Aug 16, 2019 | Sale | $10.00 | 22,700 | 227,000 | 395,101 | Aug 19, 2019, 04:08 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Young Richard A | Director | Aug 15, 2019 | Sale | $10.00 | 2,300 | 23,000 | 417,801 | Aug 19, 2019, 04:08 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | NELSEN ROBERT | 10% Owner | Jul 15, 2019 | Sale | $8.27 | 2,700 | 22,316 | 4,302,051 | Jul 17, 2019, 07:26 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | NELSEN ROBERT | 10% Owner | Jul 16, 2019 | Sale | $7.81 | 25,779 | 201,277 | 4,276,572 | Jul 17, 2019, 07:26 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | ARCH Venture Partners VII, L.P. | 10% Owner | Jul 17, 2019 | Sale | $7.70 | 34,521 | 265,687 | 4,242,051 | Jul 17, 2019, 07:26 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | AKKARAJU SRINIVAS | Director | Apr 09, 2019 | Buy | $7.50 | 533,332 | 3,999,990 | 1,593,270 | Apr 11, 2019, 04:37 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | BYBEE CLINTON | 10% Owner | Mar 12, 2019 | Sale | $7.37 | 40,092 | 295,374 | 4,432,462 | Mar 14, 2019, 06:57 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | ARCH Venture Fund VII, L.P. | 10% Owner | Mar 13, 2019 | Sale | $7.90 | 84,411 | 666,565 | 4,350,871 | Mar 14, 2019, 06:57 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | CRANDELL KEITH | 10% Owner | Mar 14, 2019 | Sale | $8.15 | 43,000 | 350,441 | 4,305,051 | Mar 14, 2019, 06:57 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | ARCH Venture Partners VII, L.P. | 10% Owner | Mar 08, 2019 | Sale | $6.93 | 84,496 | 585,270 | 4,517,432 | Mar 11, 2019, 05:58 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | BYBEE CLINTON | 10% Owner | Mar 11, 2019 | Sale | $6.49 | 44,878 | 291,366 | 4,472,554 | Mar 11, 2019, 05:58 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | NELSEN ROBERT | 10% Owner | Mar 07, 2019 | Sale | $6.87 | 35,209 | 242,013 | 4,601,928 | Mar 11, 2019, 05:58 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Simonian Nancy A | President & CEO | Nov 29, 2018 | Option Exercise | $1.23 | 110,588 | 136,224 | 481,288 | Dec 03, 2018, 04:06 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | AKKARAJU SRINIVAS | Director | Jan 31, 2018 | Buy | $9.55 | 209,424 | 1,999,999 | 1,059,938 | Feb 02, 2018, 03:53 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Springhorn Jeremy P. | Chief Business Officer | Dec 15, 2017 | Buy | $9.08 | 15,000 | 136,260 | 15,000 | Dec 15, 2017, 04:02 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | AKKARAJU SRINIVAS | Director | Dec 13, 2017 | Buy | $8.97 | 68,400 | 613,548 | 803,894 | Dec 14, 2017, 08:22 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | AKKARAJU SRINIVAS | Director | Dec 14, 2017 | Buy | $8.99 | 26,600 | 239,134 | 830,494 | Dec 14, 2017, 08:22 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | AKKARAJU SRINIVAS | Director | Dec 12, 2017 | Buy | $9.40 | 14,774 | 138,876 | 735,494 | Dec 14, 2017, 08:22 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | DeSimone Colleen Elizabeth | Principal Accounting Officer | Oct 23, 2017 | Sale | $9.55 | 1,100 | 10,505 | 550 | Oct 23, 2017, 04:44 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Young Richard A | Director | Aug 14, 2017 | Sale | $22.00 | 3,282 | 72,204 | 420,101 | Aug 16, 2017, 04:08 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Olson Eric R | Chief Scientific Officer | Aug 07, 2017 | Option Exercise | $12.30 | 5,000 | 61,494 | 2,500 | Aug 08, 2017, 05:20 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Olson Eric R | Chief Scientific Officer | Jul 25, 2017 | Sale | $11.43 | 25,000 | 285,750 | 12,500 | Jul 27, 2017, 04:09 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Young Richard A | Director | Jul 25, 2017 | Sale | $22.09 | 3,282 | 72,496 | 423,383 | Jul 27, 2017, 04:09 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Nashat Amir | Director | Jul 06, 2016 | Buy | $12.50 | 400,000 | 5,000,000 | 1,538,333 | Jul 07, 2016, 05:41 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Polaris Partners VII, L.P. | 10% Owner | Jul 06, 2016 | Buy | $12.50 | 400,000 | 5,000,000 | 1,538,333 | Jul 07, 2016, 05:41 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | AFEYAN NOUBAR | 10% Owner | Jul 06, 2016 | Buy | $12.50 | 400,000 | 5,000,000 | 3,674,660 | Jul 07, 2016, 06:04 AM | |
| SYRS | Syros Pharmaceuticals, Inc. | Green Jeremy | 10% Owner | Jul 06, 2016 | Buy | $12.50 | 432,746 | 5,409,325 | 366,739 | Jul 07, 2016, 06:03 AM | |
| SYRS | Syros Pharmaceuticals, Inc. | BYBEE CLINTON | 10% Owner | Jul 06, 2016 | Buy | $12.50 | 400,000 | 5,000,000 | 4,637,137 | Jul 07, 2016, 06:02 AM | |
| SYRS | Syros Pharmaceuticals, Inc. | NELSEN ROBERT | Director | Jul 06, 2016 | Buy | $12.50 | 400,000 | 5,000,000 | 4,637,137 | Jul 06, 2016, 09:22 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | SCHIFF ANDREW N | 10% Owner | Jul 06, 2016 | Buy | $12.50 | 400,000 | 5,000,000 | 908,565 | Jul 06, 2016, 05:10 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Deerfield Mgmt III, L.P. | 10% Owner | Jul 06, 2016 | Buy | $12.50 | 280,000 | 3,500,000 | 1,466,654 | Jul 06, 2016, 11:54 AM | |
| SYRS | Syros Pharmaceuticals, Inc. | Flynn James E | 10% Owner | Jul 06, 2016 | Buy | $12.50 | 120,000 | 1,500,000 | 628,566 | Jul 06, 2016, 11:54 AM |
Menu